The Inaugural Mass General Kidney Transplant Symposium features expert speakers and panelists from across the kidney transplant team, including nephrologists, pharmacists, social workers and more.
This dynamic program offers a unique opportunity to learn from leading experts in the field of kidney disease management and transplantation.
Learning Objectives
Upon completion of this activity, participants will be able to:
Determine complications of immunosuppression and dangerous drug-drug interactions post-transplant.
Define current immunosuppressive regimens used, target drug levels and specific drug indications post-transplant.
Recognize the risk of disease recurrence post-transplant and advances in genetics of nephrology.
Review the advantages of living donation and donor risks.
Evaluate appropriate timing of referral for transplantation and appropriate indications/contraindications for transplant, including available programs for managing challenging patients such as elderly, obese and highly sensitized patients.
Review how race and ethnicity and socioeconomic factors may affect transplant referrals, waitlisting and transplantation. Review available Massachusetts General Hospital programs and interventions to support equity in kidney transplantation.
Determine the routine clinically indicative tests to monitor the kidney transplant and novel non-invasive tests proposed to identify rejection earlier.
Define new advances in the development of artificial kidneys & xenotransplantation.
Determine the role of point-of-care ultrasound in kidney disease management.